NeuClone announces First Human dose of Stelara® (Ustekinumab) Biosimilar candidate

NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products,...

October 21, 2019 | Monday | News
Celltrion, Juno establish biosimilar partnership

Celltrion Healthcare Australia (Celltrion) and Juno Pharmaceuticals (Juno) have entered in to a co-marketing partnership...

October 18, 2019 | Friday | News
Admedus inks $A36.2M deal for CardioCel And VascuCel Patch biz

Australia based Admedus Limited announces the sale of its CardioCel® and VascuCel® patch business to U...

October 15, 2019 | Tuesday | News
George Clinical names Sean Hart as Chief Business Officer

George Clinical, a global scientifically-driven clinical research organization (CRO) has announced the promotion of Sean...

October 14, 2019 | Monday | News
Immutep receives A$2.5 M R&D tax incentive from French Govt

Immutep Limited, an Australian biotechnology company developing novel immunotherapy treatments for cancer and autoimmune...

October 14, 2019 | Monday | News
Australia grants Patent to Krystal Biotech

 Krystal Biotech ,a gene therapy company dedicated to developing and commercializing novel treatments for patients ...

October 4, 2019 | Friday | News
InMode opens new subsidiaries in APAC region

Israel based InMode Ltd., a leading global provider of innovative medical technologies, announced that it has completed ...

October 4, 2019 | Friday | News
World-first heart attack alerting technology enters Australia

Hydrix Limited has announced that it has secured the exclusive rights to distribute the AngelMed Guardian® Syst...

October 3, 2019 | Thursday | News
Mayne, Mithra bring novel oral contraception in the US

Mayne Pharma, with two product development and manufacturing facilities based in Salisbury, Australia and Gree...

October 2, 2019 | Wednesday | News
Osteopore takes its 3D bone implant printing global

Osteopore International, a Singaporean bone regeneration technology provider has debuted on the Australian Securities Ex...

September 30, 2019 | Monday | News
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval

AVITA Medical, a regenerative medicine company focused on the development and commercialization of innovative therapies ...

September 17, 2019 | Tuesday | News
Johnson & Johnson Vision introduces TECNIS Synergy IOL

Johnson & Johnson Vision, a global leader in eye health and presbyopia-correcting IOLs, on 16 Sep 2019 announced the...

September 17, 2019 | Tuesday | News
AdAlta secures licensing deal for i-body platform with GE Healthcare

Australia based biotech company AdAlta Limited has announced it has signed a commercial agreement for its i-body platfor...

September 18, 2019 | Wednesday | News
Saluda Medical announces European Commercial launch of Evoke

Australia headquartered Saluda Medical Pty Limited has announced the award of CE Mark and the European commercial launch...

September 17, 2019 | Tuesday | News
SpeeDx gets CE-IVD nod for ResistancePlus MG FleXible

Australia based SpeeDx Pty, Ltd. has announced ResistancePlus® MG FleXible for the Cepheid GeneXpert® ...

September 9, 2019 | Monday | News
Australia develops new technology for neonatal care

Researchers at the University of South Australia have successfully trialled new computer vision technology to safely mon...

September 6, 2019 | Friday | News
Spectrum Therapeutics launches first TGA registered vapouriser

Spectrum Therapeutics Australia (Spectrum), the medical division of Canopy Growth Corporation Australia (Canopy Growth),...

September 5, 2019 | Thursday | News
MediPharm Labs forms multiple cannabis supply partnerships

MediPharm Labs Corp., a global leader in specialized, research-driven cannabis extraction, distillation, purification an...

September 4, 2019 | Wednesday | News